Open AccessA long-acting formulation of the integrase inhibitor raltegravir protects humanized BLT mice from repeated high-dose vaginal HIV challenges
Author(s) -
Víctor Moreno,
Rae Ann Spagnuolo,
Justin Steve,
Bonnie J. Howell,
Caroline Baker,
Daria J. Hazuda,
Martina Kovářová,
Michael D. Swanson,
Rosa I. Sánchez
Publication year - 2020
Publication title -
unc libraries
Language(s) - English
DOI - 10.17615/50yt-m563
Subject(s) - raltegravir , humanized mouse , human immunodeficiency virus (hiv) , integrase , integrase inhibitor , pharmacology , virology , medicine , viral load , antiretroviral therapy , immunology , immune system
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom